BENTLEY GREGORY SMITH 4
4 · KV PHARMACEUTICAL CO /DE/ · Filed Sep 9, 2010
Insider Transaction Report
Form 4
KV PHARMACEUTICAL CO /DE/KVA/KVB
BENTLEY GREGORY SMITH
DirectorSenior VP - Law
Transactions
- Award
Option to Purchase
2010-09-07+35,000→ 35,000 totalExercise: $1.62Exp: 2020-09-07→ Class A Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests in five equal annual installments beginning on September 7, 2011.